Moderna

MRNANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$89.828 B

$225.00 +14.21%

Close of 12 Oct 2026

As of 12 Oct 2026, Moderna (MRNA) has a market capitalization of $89.8B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.94B

#1146 by revenue

Earnings

-$2.82B

Loss-making

Shares outstanding

399,235,889

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 159 →

#1AmgenAMGN$224.3B
#2Gilead SciencesGILD$187.4B
#3ModernaMRNA$89.8B
#4Argenx SeARGX$51.2B
#5Revolution MedicinesRVMD$40.7B

What if Moderna were worth as much as…

Open the what-if tool →

Gold $29.0T

$72,700.52

Per share 323× higher

Bitcoin $1.66T

$4,165.41

Per share 18.5× higher

Nvidia $5.53T

$13,840.56

Per share 61.5× higher

Or at a round number

$200.0B $500.0B $1.00T $2.00T

Where these numbers come from

Share counts and financials for Moderna are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 13 Oct 2026. Read the methodology.